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Abstract
Background: Devil facial tumour disease (DFTD) is a fatal contagious cancer that has decimated Tasmanian devil
populations. The tumour has spread without invoking immune responses, possibly due to low levels of Major
Histocompatibility Complex (MHC) diversity in Tasmanian devils. Animals from a region in north-western Tasmania have
lower infection rates than those in the east of the state. This area is a genetic transition zone between sub-populations, with
individuals from north-western Tasmania displaying greater diversity than eastern devils at MHC genes, primarily through
MHC class I gene copy number variation. Here we test the hypothesis that animals that remain healthy and tumour free
show predictable differences at MHC loci compared to animals that develop the disease.
Methodology/Principal Findings: We compared MHC class I sequences in 29 healthy and 22 diseased Tasmanian devils
from West Pencil Pine, a population in north-western Tasmania exhibiting reduced disease impacts of DFTD. Amplified
alleles were assigned to four loci, Saha-UA, Saha-UB, Saha-UC and Saha-UD based on recently obtained genomic sequence
data. Copy number variation (caused by a deletion) at Saha-UA was confirmed using a PCR assay. No association between
the frequency of this deletion and disease status was identified. All individuals had alleles at Saha-UD, disproving theories of
disease susceptibility relating to copy number variation at this locus. Genetic variation between the two sub-groups
(healthy and diseased) was also compared using eight MHC-linked microsatellite markers. No significant differences were
identified in allele frequency, however differences were noted in the genotype frequencies of two microsatellites located
near non-antigen presenting genes within the MHC.
Conclusions/Significance: We did not find predictable differences in MHC class I copy number variation to account for
differences in susceptibility to DFTD. Genotypic data was equivocal but indentified genomic areas for further study.
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Introduction
The Tasmanian devil (Sarcophilus harrisii) is threatened with
extinction in the wild due to the emergence of a contagious cancer
known as Devil Facial Tumour Disease (DFTD). Since its
emergence 15 years ago, devil populations have declined by at
least 95% in the longest diseased areas and there are concerns that
DFTD will lead to the extinction of this endangered marsupial
carnivore within 35 years [1,2]. DFTD is highly unusual in that it
is transmitted as an infectious cell line (an allograft) [3–5] which
spreads as devils bite and injure each other during the course of
communal feeding on carcasses and during social and reproduc-
tive interactions [6,7]. The primary DFTD tumours usually begin
on the face or inside the mouth and quickly develop into large
globular tumours, that ulcerate and become friable and metasta-
size to internal organs [4,8]. DFTD is invariably fatal, usually
within 3–6 months of the clinical presentation of visible tumours
[9]. This has clear impacts, not just on devil population size and
growth rates [10], but also age class structuring [11] and important
life history traits including dispersal [12], sex ratios [11] and age at
first reproduction [13].
One of the great challenges in managing this disease is that the
cancer and its host are highly similar, since DFTD evolved from a
Tasmanian devil Schwann cell (Schwann cells are part of the
peripheral nervous system) [14]. Tasmanian devils are renowned
for their lack of diversity across the genome [15,16] including at a
key gene region involved in immune response, the Major
Histocompatibility Complex (MHC) [5]. The MHC plays a
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critical role in self/non-self recognition. MHC molecules can
recognise antigenic peptides or cancer antigens and present them
to cytotoxic T cells for destruction. MHC molecules can also act as
antigens themselves, which is why MHC typing is used to select
appropriate donors for tissue transplantation. Due to low levels of
genetic diversity, devils frequently share the same MHC antigens
as the DFTD tumour and hence it has been suggested that the
tumour MHC antigens are not recognised by the devils as non-self
[5]. Consequently, individual devils do not mount an immune
response to DFTD [17]. We previously suggested that both the
naturally existing contagious cancers, DFTD and Canine Trans-
missible Venereal Tumour (CTVT) evolved in populations of
devils and wolves respectively that lacked MHC diversity [18]. It
was postulated that these animals were more likely to be able to
accept grafts from unrelated (but MHC identical) animals due to a
lack of histocompatibility barriers. However, recent skin graft
experiments have shown that MHC-similar devils will reject skin
grafts [19]. This demonstrates that the low MHC diversity of
devils does not necessarily mean that these animals are unable to
identify foreign tissues. However, it does not address the possible
influence that increased diversity at the MHC may have on
reducing disease transmission.
Our research group previously surveyed sequence polymor-
phism in Tasmanian devils across their range and identified a total
of 53 MHC class I sequence variants [20]. Between two and seven
MHC class I variants were amplified from each individual, but
without genomic information it was not possible to assign variants
to loci. Recent sequencing of bacterial artificial chromosomes
containing MHC inserts has allowed us to elucidate the gene
content and organisation of the devil MHC. The Tasmanian devil
MHC contains three classical class I genes (Saha-UA, Saha-UB and
Saha-UC) [21]. These loci share extremely high amino acid identity
in both exons (.98.3%) and introns (.97.7%) and account for all
sequence variants which we previously designated ‘‘group 1’’ [20].
The sequences previously classified as ‘‘group 2’’ belong to a single
locus designated Saha-UD, which shows some features of a
nonclassical class I gene such as significantly lower levels of
polymorphism [21]. Comparison of devil MHC haplotypes
revealed a deletion within the Saha-UA gene, rendering it a
pseudogene in certain haplotypes [21]. This deletion explains, to
some extent, why a differing number of sequence variants have
been detected between individuals.
It was previously suggested that individuals with a more
restricted MHC complement (presence of only ‘‘group 1’’ or only
‘‘group 2’’ alleles) may be better able to recognize the foreign
antigens on the surface of DFTD cells [20]. This is because the
tumour (which contains genes which encode both group 1 and
group 2 proteins) will therefore contain foreign MHC antigens
which are not present in the host. We test this hypothesis by using
individuals from a region of north-western Tasmania, West Pencil
Pine (‘WPP’ hereafter). There is population genetic structuring
across the island of Tasmania reflecting reduced gene flow
between devils in the large, well connected eastern population
and the more remote north-west region which is partially
geographically isolated by large swathes of unsuitable alpine and
wet forest habitat [22]. Devils in this region are genetically distinct
from those in the east of Tasmania at both neutral loci [15,16] and
at MHC genes [20]. The devils at WPP are the first population to
show reduced disease effects at both population and individual
levels, with low disease prevalence, increased survival time of
infected individuals, and little indication of changes in population
size, population growth rate or age structure, four years after the
disease was first detected [23]. Here we test the hypothesis that
MHC class I differences can explain the variant epidemiology and
host effects of DFTD at WPP. We do this by comparing the MHC
profiles of devils that have presented with tumours with those of
healthy older devils in the population (.3 years of age) who have
not developed tumours. The rationale for selecting older
individuals for the sample of uninfected devils was that they have
had maximum time within the population to come into contact
with DFTD without developing the disease. In eastern popula-
tions, virtually all devils have become infected and died of DFTD
before the age of three [1,10]. Data on contact rates and biting
behavior of devils at WPP suggests that it is unlikely that mature
adults that are mating and fighting would not have come into
contact with DFTD by this age [6, R.H. unpublished data],
particularly as the population is shown to act as one social unit
[24].
We discover that mismatches in previously published polymer-
ase chain reaction (PCR) primers result in inconsistent amplifica-
tion of MHC alleles and turn to MHC-linked microsatellites to
look for differences between the affected and unaffected groups,
which proves to be an efficient alternative to cloning-and-
sequencing based MHC typing in investigating genetic diversity
and natural selection at MHC loci [25–27].
Results and Discussion
Tasmanian Devil MHC Class 1 Sequence
By establishing the presence/absence of alleles at the Saha-UA
and Saha-UD loci via PCR assays, we detected no significant
differences in MHC class I copy number between 22 diseased
devils and 29 healthy controls from WPP. We propose that
previous findings to the contrary were the result of inconsistent
primer amplification. Sequencing of the MHC class I peptide
binding region identified 27 different alleles including six variants
previously undescribed. The six new alleles all clustered neatly
within what was formerly referred to as the ‘‘group 1’’ clade of
sequences (according to Siddle et al) [20] (Saha-UA, UB and UC
loci according to Cheng et al) [21] and have been assigned
GenBank accession numbers JN397396–JN397401.
Alleles were assigned to four loci (Saha-UA, UB, UC and UD)
based on phylogenetic analysis (Table 1). Sequences associated
with the Saha-UD locus were more divergent from the other loci,
but overall sequence variation was still low and characterized by
nucleotide identities of between 85–99% and amino acid identities
of 74–100%. Saha-UD had the fewest alleles (four) and the highest
within group nucleotide identities of 98–99% and amino acid
identities of 96–100%. Locus Saha-UB had the largest number of
alleles (ten) and the lowest within-group nucleotide identities of
96–99% and amino acid identities of 91–99%. Saha-UA and UC
had six and seven alleles respectively and intermediate levels of
nucleotide diversity. When alleles were translated into amino
acids, all were non-synonymous with the exception of SahaI*32
and SahaI*39, which produced identical amino acid profiles
(Table S1).
PCR primer efficiency was assessed for each locus, revealing the
highest amplification failure rate of 43.14% at Saha-UD (Table 1).
Locus specific primers for Saha-UD showed that all individuals had
at least one allele and therefore previously reported copy number
variation at this locus (‘group 2’) was the result of primer
mismatches. Primer design represents one of the major technical
challenges in MHC studies [28,29]. In our case, the primer
mismatches (two in Saha-UA, UB and UC, four in Saha-UD) were
identified only after recent sequencing of BAC contigs for the devil
MHC regions [21]. In the devil, copy number variation exists
between different MHC haplotypes due to a deletion at the Saha-
UA locus, making it more difficult to resolve whether differing
MHC of Healthy and Tumour-Afflicated Devils
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Table 1. Tasmanian devils sequenced using the MHC class I primers developed by Siddle et al [41] and screened for a deletion at
the Saha-UA locus in this same gene region.
Disease
status Name
Deletion at
Saha-UA locus
Alleles at
Saha-UA locus
Alleles at
Saha-UB locus
Alleles at
Saha-UC locus
Alleles at
Saha-UD locus Missing data
Healthy Allende 3 SahaI*35 SahaI*49 SahaI*27 Saha-UD
Baguette x SahaI*29 SahaI*38 SahaI*27 SahaI*28 SahaI*32
Cartagena x SahaI*35 SahaI*46 SahaI*49 SahaI*27 SahaI*96 SahaI*32
Chicomunita x SahaI*35 SahaI*93 SahaI*46 SahaI*49 SahaI*27 SahaI*28 Saha-UD
Chinquihue x SahaI*36 SahaI*37 Saha-UA, UC, UD
Delfina x SahaI*29 SahaI*35 SahaI*27 SahaI*28 Saha-UB, UD
Elvira 3 SahaI*35 SahaI*49 SahaI*27 SahaI*32
Estrella 3 SahaI*35 SahaI*49 SahaI*27 Saha-UD
Evaristo x SahaI*29 SahaI*27 SahaI*28 SahaI*32 Saha-UB
Gengibre x SahaI*48 SahaI*27 SahaI*53 SahaI*32 Saha-UA
Huenchullan 3 SahaI*35 SahaI*49 SahaI*27 SahaI*32
Iquique x SahaI*35 SahaI*28 SahaI*39 Saha-UB
Lascruces 3 SahaI*27 SahaI*32 Saha-UB
Lautaro x SahaI*29 SahaI*35 SahaI*47 SahaI*27 SahaI*28 Saha-UD
Limache 3 SahaI*35 SahaI*49 SahaI*27 SahaI*91 SahaI*32
Mapuche x SahaI*29 SahaI*35 SahaI*47 SahaI*27 SahaI*32
Melipilla x SahaI*35 SahaI*49 SahaI*53 SahaI*96 Saha-UD
Mirasol x SahaI*37 Saha-UA, UC, UD
Okapi 3 SahaI*27 SahaI*32 Saha-UB
Pomaire 3 SahaI*29 SahaI*27 SahaI*28 SahaI*32 Saha-UB
Puyehue x SahaI*35 SahaI*49 Saha-UC, UD
Racelette 3 SahaI*36 SahaI*94 SahaI*27 SahaI*32
Sanantonio 3 SahaI*35 SahaI*46 SahaI*28 SahaI*32
Sanvicente x SahaI*29 SahaI*35 SahaI*28 SahaI*32
Segundo x SahaI*29 SahaI*35 SahaI*49 SahaI*95 SahaI*27 SahaI*28 SahaI*32
Timoteo 3 SahaI*36 SahaI*37 SahaI*27 SahaI*32
Trancura 3 SahaI*35 SahaI*49 SahaI*27 SahaI*32 SahaI*75
Veronika x SahaI*38 SahaI*49 SahaI*80 SahaI*27 SahaI*28 SahaI*32
Vieiochoco x SahaI*35 SahaI*49 SahaI*27 Saha-UD
Diseased Aconcagua x SahaI*29 SahaI*35 SahaI*49 SahaI*27 Saha-UD
Amor x SahaI*35 SahaI*49 SahaI*27 SahaI*32
Arica 3 SahaI*35 SahaI*28 SahaI*32 Saha-UB
Calafquen x SahaI*35 SahaI*92 SahaI*49 SahaI*27 SahaI*28 SahaI*32
Cassolette 3 SahaI*35 SahaI*46 SahaI*28 SahaI*32 SahaI*67
Concon 3 SahaI*27 SahaI*32 Saha-UB
Copiapo x SahaI*46 SahaI*49 SahaI*27 SahaI*28 Saha-UA, UD
Curanto 3 SahaI*35 SahaI*47 Saha-UC, UD
Fabulosa 3 SahaI*29 SahaI*80 SahaI*27 SahaI*28 Saha-UD
Infima 3 SahaI*49 SahaI*27 SahaI*28 Saha-UD
Loncoche 3 SahaI*35 SahaI*49 SahaI*95 Saha-UC, UD
Malagente 3 SahaI*29 SahaI*27 SahaI*28 Saha-UB, UD
Marquez 3 SahaI*27 SahaI*32 Saha-UB
Mistral 3 SahaI*29 SahaI*27 SahaI*28 SahaI*32 Saha-UB
Negrita x SahaI*29 SahaI*35 SahaI*49 SahaI*30 Saha-UD
Olmue x SahaI*35 SahaI*33 SahaI*28 SahaI*91 Saha-UD
Princessa x SahaI*35 SahaI*92 SahaI*49 SahaI*27 SahaI*28 SahaI*32
Renaca 3 SahaI*35 SahaI*46 SahaI*28 Saha-UD
Ruudgullit x SahaI*29 SahaI*79 SahaI*36 SahaI*94 SahaI*27 SahaI*32
MHC of Healthy and Tumour-Afflicated Devils
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numbers of alleles/genes are real or simply the result of primer
inefficiency. Due to the high sequence similarity of Saha-UA, Saha-
UB and Saha-UC it is impossible to develop locus specific primers
for these loci. Previous sequencing of the devil MHC provided no
evidence of a deletion at either Saha-UB or Saha-UC [21] and
further work is underway to determine if copy number variations
observed at these loci are real, or the result of poor sequence
amplification. No significant differences were found between
healthy and diseased devils in the frequency with which alleles
failed to amplify at any of the four loci (Saha-UA p= 1.0; Saha-UB
p= 0.76; Saha-UC p= 1.0; Saha-UD p= 0.17).
A specific PCR test was used to determine the frequency of copy
number variation of Saha-UA as a result of a deletion at this locus.
A deletion at Saha-UA occurred in 45.01% of all devils (Table 1).
There was no significant difference between the two groups
(healthy and diseased) in the frequency of this deletion (p= 0.58). It
should be noted that the PCR test used to detect the deletion
cannot resolve whether the deletion occurs in one or both
haplotypes in the individual. Therefore, the association between
missing one or two Saha-UA in a devil and the extent of DFTD
susceptibility remains to be determined.
Given the difficulties in differentiating real copy number
variations from artifactual variations, we chose to employ MHC-
linked microsatellite markers to assist in MHC typing healthy and
diseased devils. These microsatellites are linked to various genes
within the MHC region, including markers located close to each of
the four MHC class I loci (Saha-UA, Saha-UB, Saha-UC, Saha-UD:
Fig. 1) [30].
Population Genetics Using Neutral and MHC-linked
Microsatellite Markers
Nine neutral microsatellite markers provided a background for
assessing selection on the MHC [31]. All neutral markers
conform to Hardy-Weinberg expectations and display similar
numbers of alleles, allele frequencies and levels of heterozygosity
for diseased and healthy animals (Table 2). Population pairwise
FST= 0.005 (p = 0.2160.004) indicates no significant difference
between diseased and healthy animals at these loci. As no
demographic factors such as migration or assortative mating are
evident in the neutral markers, any deviations from Hardy-
Weinberg equilibrium observed at MHC-linked loci may be
attributed to selection.
The eight MHC-linked microsatellite markers also display
similar levels of heterozygosity, allele frequencies and identical
numbers of alleles for diseased and healthy devils (Fig. 2, Table 2).
Linkage disequilibrium was high for almost all MHC-linked loci,
which is expected as they all map to chromosome 4 q [30] (Fig. 1).
While heterozygosity was relatively high for some loci (Sh-I01, Sh-
I07, Sh-I08), Hardy-Weinberg expectations held for all but one
locus (Sh-I07) for healthy devils only (p = 0.003, Table 2). This
remained significant after sequential Bonferroni correction. In
sum, these results suggest no strong heterozygote advantage nor
the presence of DFTD-resistance alleles. Further, population
pairwise FST= 0.0007 (p= 0.4160.006) indicates no differentia-
tion between diseased and healthy devils.
The frequency of genotypes in the population was also
assessed. This measure is particularly sensitive to changes over
short time scales (allele frequencies take longer to change in a
population than genotype frequencies), which is relevant consid-
ering the recent arrival of DFTD in the region. Microsatellite
markers located closest to antigen presenting MHC class I loci
(Sh-I01, Sh-I02, Sh-I05, Sh-I06, Sh-I10, Sh-I11) had low allelic
(Fig. 2) and genotype diversity (Fig. 3a), possibly the result of a
selective sweep due to a prior disease epidemic [32,33]. Two
markers (Sh-I07 and Sh-I08) are located within the MHC but
are closest to non-antigen presenting genes, MTCH1 and FGD2
(Fig. 3). Both loci have considerably higher polymorphism with
six alleles each and 10–15 genotypes (mean 12.5), compared to
2–4 alleles (mean 2.83) and 3–7 genotypes (mean 4.67) in the six
remaining markers which are located closest to genes involved in
antigen presentation.
Table 1. Cont.
Disease
status Name
Deletion at
Saha-UA locus
Alleles at
Saha-UA locus
Alleles at
Saha-UB locus
Alleles at
Saha-UC locus
Alleles at
Saha-UD locus Missing data
Saucisette x SahaI*35 SahaI*92 SahaI*48 SahaI*49 SahaI*74 Saha-UD
Tartiflette x SahaI*29 SahaI*35 SahaI*49 SahaI*27 SahaI*28 SahaI*32
Tranamil x SahaI*46 SahaI*28 Saha-UA, UD
Summary 45.01% deleted 9.80%
missing
25.49%
missing
9.80%
missing
43.14%
missing
In each individual devil the loci which can be confirmed as failing to amplify are identified (as indicated by no alleles present). No significant differences were found
between healthy and diseased animals in the prevalence of the Saha-UA deletion or in the frequency with which alleles failed to amplify at any loci.
doi:10.1371/journal.pone.0036955.t001
Figure 1. Location of eight MHC-linked microsatellites on devil chromosome four, associated with the MHC region. Six of these (Sh-
I01, Sh-I02, Sh-I05, Sh-I06, Sh-I10 and Sh-I11) are located close to the four MHC class I loci (Saha-UA, Saha-UB, Saha-UC and Saha-UD) and several other
genes involved in antigen presentation (TAP1, TAP2, PSMB8, PSMB9). The two remaining markers (Sh-I07, Sh-I08) are more closely linked with genes
within the MHC that do not play a direct role in antigen presentation (MTCH1, FGD2).
doi:10.1371/journal.pone.0036955.g001
MHC of Healthy and Tumour-Afflicated Devils
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Table 2. Neutral and MHC-linked microsatellite loci summary statistics for diseased (shaded rows) and healthy devils.
Neutral loci MHC-linked loci
Locus FIS A Ho/He HWE p value (±s.d.) Locus FIS A Ho/He HWE p value (±s.d.)
Sh2i 0.215 3 0.44/0.56 0.388 (60.001) ShI01 20.240 3 0.82/0.67 0.333 (60.001)
0.274 3 0.28/0.38 0.059 (60.001) 20.018 3 0.68/0.67 0.134 (60.001)
Sh2g 20.048 3 0.50/0.48 0.723 (60.001) ShI02 0.051 2 0.41/0.43 1.000 (60.000)
0.091 3 0.45/0.50 0.137 (60.001) 0.171 2 0.39/0.47 0.435 (60.002)
Sh2v 0.046 5 0.68/0.71 0.111 (60.001) ShI05 0.102 2 0.38/0.42 0.660 (60.002)
0.017 4 0.67/0.68 0.916 (60.001) 0.277 2 0.32/0.44 0.209 (60.001)
Sh5c 20.099 3 0.59/0.54 0.893 (60.001) ShI06 20.051 2 0.48/0.46 1.000 (60.000)
0.194 3 0.40/0.49 0.323 (60.001) 0.030 2 0.45/0.47 1.000 (60.000)
Sh6e 0.010 2 0.33/0.34 1.000 (60.000) ShI07 20.107 5 0.79/0.71 0.753 (60.001)
20.191 2 0.34/0.29 0.556 (0.001) 20.092 5 0.76/0.70 0.003 (±0.000)*
Sh6L 0.315 2 0.25/0.36 0.119 (60.001) ShI08 20.053 6 0.76/0.72 0.940 (60.001)
0.142 2 0.36/0.42 0.640 (60.002) 20.040 6 0.81/0.78 0.169 (60.001)
Sh2L 20.059 2 0.14/0.14 1.000 (60.000) ShI10 0.097 3 0.45/0.50 0.465 (60.002)
20.019 2 0.07/0.07 1.000 (60.000) 20.120 4 0.31/0.28 1.000 (60.000)
Sh2p 20.104 4 0.68/0.62 0.889 (60.001) ShI11 20.007 4 0.64/0.64 0.465 (60.002)
20.014 3 0.46/0.46 1.000 (60.000) 0.290 3 0.45/0.63 0.153 (60.001)
Sh3a 20.027 2 0.44/0.43 1.000 (60.000)
0.006 2 0.48/0.48 1.000 (60.000)
A single locus (Sh-I07) displays a departure from Hardy-Weinberg equilibrium for healthy devils only. Numbers of alleles and levels of heterozygosity are very similar for
healthy and DFTD infected devils though with a slight trend for higher heterozygosity in infected devils.
*denotes statically significant departure from Hardy-Weinberg equilibrium (HWE). FIS indicates homozygote (+ve) or heterozygote (2ve) excess. A is the number of
alleles. Ho/He is observed and expected heterozygosities.
doi:10.1371/journal.pone.0036955.t002
Figure 2. MHC-linked microsatellite loci allele frequencies showing little variation between healthy and DFTD infected devils. A
single locus (Sh-I07) does not conform to Hardy-Weinberg expectations for healthy devils only (p = 0.003).
doi:10.1371/journal.pone.0036955.g002
MHC of Healthy and Tumour-Afflicated Devils
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Monte Carlo analysis of genotype distributions showed that the
actual distribution of genotypes, when compared across the two
subgroups (healthy and diseased), differed significantly from
10,000 randomly generated distributions for one locus (Sh-I07
p= 0.04). Fishers exact test was then used to investigate in more
detail which particular genotypes differed in frequency between
healthy and diseased devils. Three differences were identified in
genotype frequency at two separate loci, which were significant
before sequential Bonferroni correction (Sh-I07 genotype 173/
185, p = 0.041 and 185/187, p = 0.024; Sh-I08 genotype 223/225,
p = 0.024: Fig. 3b), though not afterwards due to the large number
of comparisons. These differences warrant further investigation,
Figure 3. Genotype frequencies for healthy and DFTD infected devils. (A) At the six microsatellite loci associated with antigen-presenting
genes within the MHC (Sh-I01, Sh-I02, Sh-I05, Sh-I06, Sh-I10 and Sh-I11). No deviations from Hardy-Weinberg equilibrium are observed for either
healthy or DFTD infected devils. (B) For two microsatellite markers more closely associated with non-antigen presenting genes within the MHC region
(Sh-I07 and Sh-I08). The Sh-I07 locus is out of Hardy-Weinberg equilibrium for healthy devils only (p = 0.029) and the Sh-I08 locus does not conform to
Hardy-Weinberg equilibrium at the 0.1 significance level (p = 0.076). Three differences in genotype frequencies were significant before Bonferroni
correction (Sh-I07:173/185, p = 0.041 and 185/187, p = 0.024; Sh-I08:223/225, p = 0.024).
doi:10.1371/journal.pone.0036955.g003
MHC of Healthy and Tumour-Afflicated Devils
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and future work will focus on increasing the number of markers in
these regions.
As mentioned above, both Sh-I07 and Sh-I08 are located
within the MHC, but are physically located closer to non-antigen
presenting genes than to antigen presenting genes. Sh-108 is
located 14.4 kb upstream of MTCH1 (also referred to as PSAP),
an evolutionarily conserved gene important in mitochondrial
transport [34]. Interestingly, this gene plays a key role in
apoptosis – a form of programmed cell death which is crucial in
maintaining health as it eliminates old and unhealthy cells [35–
37]. Sh-I07 is found 5.5 kb away from FGD2, a gene primarily
responsible for the formation of microskeletal structures [38].
This gene also plays a role in immunity via leukocyte signaling
and it is known to be expressed in B lymphocytes, macrophages
and dendritic cells [39]. In all cases it is possible that the signals
we are detecting are simply due to a hitchhiking effect and that
use of additional markers within the region may help pinpoint
stronger associations.
Conclusions and Implications for Tasmanian Devil
Management
The reduced effects of DFTD at the north-western site of WPP,
including low disease prevalence and no population decline [23]
are not due to copy number variation of MHC class I ‘group 2’
(Saha-UD) alleles, as previously proposed [20]. We show that
perceived differences at this locus are due to inconsistent primer
amplification as all individuals are confirmed to have alleles
present. No differences are detected between healthy and diseased
devils in either the frequency of MHC-linked microsatellite alleles
(indicating no ‘resistance/susceptibility’ alleles) or in the preva-
lence of a deletion of locus Saha-UA, signifying no influence of copy
number variation at this locus. The results of genotype frequency
analysis are equivocal with some evidence that certain genotypes
are more frequently encountered in healthy devils. As the
significance of differences in individual genotype frequencies
disappeared after Bonferroni correction, we cannot rule out the
possibility that these differences are due to chance, though they do
present these genes as being of interest for further study. Future
work should aim to increase sample sizes and the number of
markers in the region to determine whether these results are real
or the result of chance alone.
The different epidemiology of DFTD in WPP is currently
unexplained. The possibility remains that the uninfected devils
used in our analysis may have the disease but not yet developed
tumours or that they have simply not yet come into contact with
the disease. Both of these explanations are plausible but unlikely.
The latency state, between infection and the presentation of
tumours, is estimated to average 6 months but could be at least 10
months [1, R.H. unpublished data]. Low disease prevalence
among adults (13%) observed in WPP at the time of this study,
relative to a large devil population (300 individuals trapped
between 2006 and 2011), means that the number of ‘latent’
animals would be low. Older devils greater than three years of age
were specifically selected for our analysis as they have had
maximum opportunity for exposure to DFTD including social and
reproductive interactions which involve biting. By three years of
age virtually all devils in eastern Tasmania have succumbed to the
disease and the remainder die within months [1,10]. While there is
no current evidence that animals at WPP differ from those in the
east in behaviours linked to disease transmission, we suggest
modeling the disease risks of each population as a research
priority.WPP provides our best hopes of determining whether
genetic resistance to DFTD exists. Future studies will continue to
target the MHC, as well as expanding to look genome-wide, using
techniques such as SNPs (single nucleotide polymorphisms) and
next generation sequencing to identify the impact that immune
gene variants have on disease susceptibility.
Methods
Ethics Statement
The field research was carried out with approval from the
University of Tasmania’s Animal Ethics Committee (A0010296)
and from the Tasmanian Department of Primary Industries and
Water (TFA 08211).
Study Site and Sample Collection
West Pencil Pine (41u 319 S, 145u 469 E) is a 25 km2 area
situated on private production forestry land to the west of Cradle
Mountain in northwest Tasmania. This study site was established
in May 2006 (when the disease was first detected in the region),
following three exploratory expeditions aimed at locating the
epidemic front. We subsequently sampled this population four
times per year, from August 2006 until May 2010, at three month
intervals. Forty carnivore traps were set for 10 nights each trip. All
individuals caught were individually marked using implantable
microchip transponders and a 3 mm biopsy of ear tissue was taken
using a sterile biopsy punch. Due to the regularity with which this
site has been monitored, most of the individuals in our data set
were originally captured as sub-adults and are therefore of known
age. We aged devils first captured as adults using a combination of
molar eruption, molar tooth wear and canine over eruption. This
method is considered precise for ageing devils up to three years of
age (M.J., unpublished data). Disease status was assessed by
histopathological examination of biopsies from tumours [8], or
when this was not possible, by visual inspection and identification
of tumours [9].
The healthy and diseased devils were trapped and genetically
sampled between May 2006 and May 2010. All the healthy,
tumour-free devils used in this study were greater than three years
old at the time of capture and had co-existed with DFTD infected
individuals at least since sexual maturity for males, and for most
females, for their entire lives (devils have male-biased natal
dispersal) [12].
DNA Extraction and MHC Class I Sequencing
Total genomic DNA was extracted from ear biopsies using the
Hot-SHOT extraction method [40]. A fragment that targeted the
MHC class I a 1 domains (exon 2), was amplified in polymerase
chain reactions (PCR) utilizing primers developed by Siddle et al.
[41]. Amplification reactions were 25 mL volume and comprised;
1 x High Fidelity Buffer (Invitrogen) consisting of 60 mM Tris-
HCl (pH 8.9) and 18 mM (NH4)2SO4, 2 mM MgSO4,
0.2 mM dNTPs, 0.5 mM forward and reverse primers, 1.5 U of
Platinum Taq DNA Polymerase High Fidelity (Invitrogen) and
approximately 10 ng of template DNA. PCR amplification of
double-stranded product was performed with a MJ Mini Personal
Thermocycler (Biorad) using a cycling profile consisting of an
initial denaturing step of 94C for 3 mins followed by 35 cycles of
94C for 30 s, 60C for 30 s and 72C for 30 s. This was followed by
a final extension at 72C for 20 mins. PCR products were checked
for quality on a 1% agarose gel and DNA concentration measured
using a Nano Photometer (Implen). Bands of approximately
300 bp in size were extracted from agarose gels using an Ultra
Clean DNA Purification Kit (MoBio) and cloned into pGEM-T
easy vector (Promega) according to the manufacturer’s protocol.
Colonies with inserts of the predicted size were inoculated into LB
broth, grown overnight, and DNA was extracted using a QIAprep
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spin miniprep kit (Qiagen). In total 10 clones each from two
separate PCRs were sequenced per individual, resulting in a total
of 1060 sequences (sequencing performed by Australian Genome
Research Facility, Queensland).
Sequences were aligned and quality-checked using Bioedit
v7.0.9 [42]. All sequences containing ambiguous nucleotides were
removed from analysis. To confirm the validity of new sequence
variants and establish that they were not the result of PCR error,
new sequences had to occur in a minimum of two separate PCR
amplifications (ie., either two separate PCRs of the same individual
or PCRs of two different devils). All new sequences were translated
into amino acids using the standard genetic code and checked for
the presence of stop codons in MEGA v 5 [43]. Novel nucleotide
sequences were submitted to Genbank. They were placed in the
context of other, previously identified devil MHC sequences via
phylogenetic analysis. MEGA v 5 [43] was used to build a
neighbor joining tree using Jukes-Cantor distance with 1000
bootstraps, consistent with the methods used to build the
phylogeny of marsupial class I sequences [44].
Two PCR tests were performed to confirm the existence of
Saha-UA and Saha-UD in each individual. The copy number
variation at Saha-UA was detected following the protocol described
previously [21]. A new pair of primers (forward 59- ATGGATA-
GAGAAGATGGAGAAT -39 and reverse 59- CTGGTTGTAG-
TAGCCGTGTA -39) were designed to specifically amplify a
121 bp segment within the a1 domain of Saha-UD at the following
conditions: 94uC initial denaturation for 3 min; 32 cycles of 94uC
denaturation for 30 s, 56uC annealing for 30 s, 72uC extension for
30 s; and 72uC final extension for 10 min.
Microsatellite Genotyping
Eight molecular markers linked to MHC-loci [30] were used to
genotype 29 diseased and 31 healthy Tasmanian devils. Note that
sample number includes seven additional diseased animals than
were used in sequencing and two additional healthy animals.
Other than the inclusion of these extra nine devils, the same
individuals were used for both sequencing and microsatellite
analyses. Microsatellite loci were amplified in 15 mL reactions
using approximately 10 ng of genomic DNA with
0.2 mM dNTPs, 1 x PCR buffer (containing 15 mM MgCl2),
additional 2 mM MgCl2, 0.5 mM unlabelled primer, 0.05 mM
primer labeled with M13 (221) tail, 0.5 mM universal fluorescent-
labelled M13(221) primer, 25 ng/mL BSA (Bovine Albumin
Serum) and 0.05 U of Taq DNA polymerase (Qiagen). Forward
and reverse primers were labeled as in Cheng et al [30]. PCR
reactions were performed with a MJ Mini Personal Thermocycler
(Biorad) under the following conditions: 94uC for 3 mins, 6 cycles
of 94uC for 30 s, 60uC for 30 s and 72uC for 30 s using a
touchdown program with the annealing temperature decreasing
by 1uC per cycle for a final temperature of 54uC; 30 cycles of 94uC
for 30 s, 54uC for 30 s, 72uC for 30 s and a final extension of 72uC
for 10 mins.
Nine neutral microsatellite markers [45] were also used to
genotype the same 29 DFTD-infected and 31 healthy animals.
Neutral loci were amplified in 15 mL reactions using approxi-
mately 10 ng of genomic DNA, 0.2 mM dNTPs, 1 x PCR buffer
(containing 15 mM MgCl2), additional 0.5 mM MgCl2, 0.2 mM
forward and reverse primers labeled as in Jones et al [45]
(fluorescent labels: Applied Biosytems) 0.025 U of Taq DNA
polymerase (Qiagen). Reactions were performed with a MJ Mini
Personal Thermocycler (Biorad) under the following conditions:
94uC for 1.45 mins, 6 cycles of 94uC for 15 s, 60uC for 20 s and
72uC for 15 s using a touchdown program with the annealing
temperature decreasing by 1uC per cycle for a final temperature of
54uC; 30 cycles of 94uC for 15 s, 54uC for 20 s, 72uC for 10 s and
final extension of 72uC for 2 mins.
The amplified products were separated by electrophoresis on an
ABI 3130XL sequencer (Applied Biosystems) and scored against
the size marker LIZ 500 using Genemarker v 1.95 (Soft Genetics
LLC).
Analysis
The frequency of a deletion at the Saha-UA locus was compared
between healthy and diseased devils using two-tailed Fisher’s Exact
Test in SPSS version 18 (SPSS Inc). This same method was used to
compare the likelihood of the primers failing to amplify alleles a
given locus in either healthy or diseased animals. Cases where only
one allele was detected may be the result of a failure to amplify,
but conversely the individual may be homozygous. For this reason
only when a locus was missing all alleles did we consider this
conclusive evidence of non-amplification.
Population genetic (microsatellite) analysis was performed using
Arlequin: version 3.11 [46] and FSTAT: version 2.9.3.2 [47].
Hardy-Weinberg equilibrium was calculated in Arlequin via an
exact test using a Markov chain (forecasted chain length: 100,000,
dememorisation steps: 5000) [48]. Population structure was
analysed using Arlequin to calculate FST values (distance method,
10,100 permutations) as well as FIS for each category- diseased and
healthy. FSTAT was used to calculate linkage disequilibrium.
Allele and genotype frequencies were calculated using GenAlEx
[49] and compared between subgroups using two-tailed Fishers
Exact Test in SPSS version 18 (SPSS Inc). Allelic diversity and
observed and expected heterozygosities were calculated with
Arlequin and results were corrected by sequential Bonferroni
analysis [50]. A Monte Carlo test of randomization was used to
assess whether the observed distribution of genotypes at each locus
differed significantly from 10,000 randomly generated distribu-
tions. Compared to parametric tests, Monte Carlo procedures are
more robust to small and unbalanced datasets [51]. The program
PopTools v 3.2 [52] provided the shuffle algorithm for generating
random distributions as well as the difference statistic used for the
Monte Carlo simulation. P values were calculated according to the
number of times the actual distribution of genotypes across the two
disease statuses (diseased and non-diseased) fell outside the
confidence limits (lower percentile = 0.025, upper percen-
tile = 0.975) of 10,000 randomly generated distributions.
Supporting Information
Table S1 Amino acid sequences of all Tasmanian devil
MHC class I alleles amplified in this study. The consensus
sequence is SahaI*27 and all polymorphic residues are shown.
(DOCX)
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